Cargando…
Methimazole-induced myositis: a case report and review of the literature
Methimazole is an anti-thyroid drug commonly used to treat hyperthyroidism and is a relatively safe medication. Several side effects have been reported and usually develop within 3 months of therapy. Well-known adverse reactions include agranulocytosis, hepatitis, skin eruptions, and musculoskeletal...
Autores principales: | Bou Khalil, R, Abou Salbi, M, Sissi, S, El Kara, N, Azar, E, Khoury, M, Abdallah, G, Hreiki, J, Farhat, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921996/ https://www.ncbi.nlm.nih.gov/pubmed/24616760 http://dx.doi.org/10.1530/EDM-13-0008 |
Ejemplares similares
-
Hepatotoxicity in hyperthyroid patient after consecutive methimazole and propylthiouracil therapies
por: Gomez-Peralta, Fernando, et al.
Publicado: (2018) -
Subacute thyroiditis associated with thyrotoxic periodic paralysis after COVID-19 vaccination: a case report
por: Murashita, Mone, et al.
Publicado: (2022) -
Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS)
por: Dijkman, Benthe A M, et al.
Publicado: (2023) -
Painful fat necrosis resulting from insulin injections
por: Hanson, P, et al.
Publicado: (2014) -
Central serous chorioretinopathy secondary to intramuscular testosterone therapy
por: Lockhart, M, et al.
Publicado: (2023)